El Vínculo El Vínculo.
Closed European Union SuppliesFramework agreement

Tests, reagents and consumables for immunological analyzer Immulite 2000,,or equivalent,,

Buyer: PHI Clinical Hospital Tetovo

Published
3 March 2025
Submission deadline
27 March 2025, 12:00
Place of performance
MK006
Procedure
Open procedure
Documents
1
Notice number
00138429-2025
Reference
18dac0f0-0554-40bc-ad61-b0c32e9a365f
Official source
Official source

CPV codes

Description

Tests, reagents and consumables for immunological analyzer Immulite 2000,,or equivalent,,

Lots (38)

LotDescriptionCPV codeAmount
1 Follicle-stimulating hormone (FSH) determination tests applicable to the Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
2 Luteinizing hormone (LH) determination tests applicable to Immulite 2000 or equivalent device
MK006
33696500 Reactivos de laboratorio
3 Tests for determining estradiol (E2) applicable to the Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
4 Prolactin (PRL) determination tests applicable to Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
5 Progesterone (PRG) determination tests applicable to Immulite 2000 or equivalent device
MK006
33696500 Reactivos de laboratorio
6 Testosterone determination tests (TES) applicable to Immulite 2000 or equivalent device
MK006
33696500 Reactivos de laboratorio
7 Helicobacter pylori immunoglobulin G (HPG) assays applicable to the Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
8 Prostate acid phosphatase (PAP) assays applicable to Immulite 2000 or equivalent device
MK006
33696500 Reactivos de laboratorio
9 Pregnancy-associated plasma protein A (PAPP-A) tests applicable to the Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
10 Tests for determining free beta human chorionic gonadotropin (Free Beta HCG) applicable for Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
11 Software for prenatal screening of the risk of chromosomal disorders for reagents applicable to the Immulite2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
12 Alpha feto protein (AFP) assays applicable to the Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
13 Tests for determining human chorionic gonadotropin (HCG) applicable to the Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
14 Tests for determining free estriol applicable to the Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
15 Cortisol (COR) determination tests applicable to Immulite 2000 or equivalent device
MK006
33696500 Reactivos de laboratorio
16 Tests for determining sex-binding globulin (SHBG) applicable to the Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
17 Tests for the determination of dehydroepiandrosterone sulfate (DHEA-SO4) applicable to the Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
18 Tests for determining adrenocorticotropic hormone (ACTH) applicable to the Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
19 Androstenedione (AND) determination tests applicable to Immulite 2000 or equivalent device
MK006
33696500 Reactivos de laboratorio
20 Tests for determining intact parathyroid hormone (i-PTH) applicable to the Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
21 D-Dimer tests applicable to Immulite 2000 or equivalent device
MK006
33696500 Reactivos de laboratorio
22 Control for determining D-Dimer dimers applicable for Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
23 Control for determination of sex-binding globulin SHBG applicable for Immulite2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
24 Control for determination of intact parathyroid hormone (i-PTH) applicable for Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
25 Human chorionic gonadotropin dilution agent (hcg sample diluent) applicable for Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
26 Prostate acid phosphatase control applicable to the Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
27 Pregnancy control associated with plasma protein A applicable to the Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
28 Control for free human chorionic gonadotropin applicable for Immulite 2000 device or equivalent
MK006
33696500 Reactivos de laboratorio
29 Substrate (enzyme amplifier – phosphate ester of adamantine dioxetane in aminomethylpropanol with polyvinylbenzyltributylphosphonium chloride) applicable to Immulite2000 apparatus or equivalent
MK006
33696500 Reactivos de laboratorio
30 Instrument cleaning agent (phosphate buffered saline, < 0.9% concentration) applicable to Immulite2000 or equivalent instrument
MK006
33696500 Reactivos de laboratorio

Official publications

Other tenders from PHI Clinical Hospital Tetovo

See all →

Frequently asked questions

What is the deadline to bid for this tender?
The submission deadline is 27 March 2025, 12:00. Check the official source, as dates can be modified.
Who is the buyer of this tender?
The contracting authority is PHI Clinical Hospital Tetovo (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.